2023 annual financial data
Amphastar Pharmaceuticals, Inc. 2023 Operating margin
Amphastar Pharmaceuticals, Inc. 2023 operating margin with verified reported va…
Direct answer
Operating margin was 30.57%.
Operating income was 196,987,000 USD and net income was 137,545,000 USD.
Operating cash flow was 183,503,000 USD.
Get free Amphastar Pharmaceuticals, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 644,395,000 USD
- Operating income
- 196,987,000 USD
- Net income
- 137,545,000 USD
- Operating cash flow
- 183,503,000 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Amphastar Pharmaceuticals, Inc. financial years